Rochester General Health System Suspends Use of Power Morcellator in Gynecologic Surgeries

April 23, 2014

Rochester General Health System is, effective immediately and until further notice, suspending the use of power morcellation in gynecologic surgeries, including hysterectomies.

The Food and Drug Administration (FDA) has issued an advisory stating that the use of power morcellation in some surgeries may spread cancer.
Morcellation is a technique used in minimally invasive/robotic uterine surgery that uses a power tool to cut tissue while still in the body so it can be removed through the smaller incisions.

“Upon review of the FDA communication, RGHS is suspending use of the power morcellator until further notice,” said Eugene Toy MD, Chief, OB-GYN/RGHS. “A formal policy regarding the use of morcellation in gynecologic surgery will be established next month during a special meeting of the GYN OR committee.”

Dr. Toy says that patients scheduled to have surgery with the use of power morcellation will be counseled on this policy change and offered alternative surgical options in the meantime.

Recent News

Brian Wright, CEO of ACM Labs.
Rochester Regional Health has announced that its wholly-owned subsidiary, ACM Global Laboratories, has hired Brian Wright to lead ACM Global.

Friday, November 30, 2018

ACM Global Appoints Brian Wright as President

Rochester Regional Health has announced that its wholly-owned subsidiary, ACM Global Laboratories, has hired Brian Wright to lead ACM Global.

Read News Article
Gynecology Surgery award image
For the third time, Rochester General Hospital has received accreditation from the Surgical Review Corp as a Center of Excellence in Minimally Invasive Gynecology (COEMIG).

Thursday, November 29, 2018

Excellence in Minimally Invasive Gynecology Surgery

For the third time, Rochester General Hospital has received accreditation from the Surgical Review Corp as a Center of Excellence in Minimally Invasive Gynecology (COEMIG).

Read News Article
View All Recent News Articles